Order Article Reprints

Frangieh J, Legendre C, Bréard D, Richomme P, Henrion D, Fajloun Z, Mattei C, Le Ray A-M, Legros C. Oxostephanine, Thalmiculine, and Thaliphyline—Three Isoquinoleine Alkaloids That Inhibit L-Type Voltage-Gated Ca²⁺ Channels. Future Pharmacology. 2022; 2(3):238-255. https://doi.org/10.3390/futurepharmacol2030016

Frangieh, Jacinthe, Claire Legendre, Dimitri Bréard, Pascal Richomme, Daniel Henrion, Ziad Fajloun, César Mattei, Anne-Marie Le Ray, and Christian Legros. 2022. "Oxostephanine, Thalmiculine, and Thaliphyline—Three Isoquinoleine Alkaloids That Inhibit L-Type Voltage-Gated Ca²⁺ Channels" Future Pharmacology 2, no. 3: 238-255. https://doi.org/10.3390/futurepharmacol2030016

Frangieh, J., Legendre, C., Bréard, D., Richomme, P., Henrion, D., Fajloun, Z., Mattei, C., Le Ray, A.-M., & Legros, C. (2022). Oxostephanine, Thalmiculine, and Thaliphyline—Three Isoquinoleine Alkaloids That Inhibit L-Type Voltage-Gated Ca²⁺ Channels. Future Pharmacology, 2(3), 238-255. https://doi.org/10.3390/futurepharmacol2030016